Checkpoint inhibitors can only amplify an antitumor immune response that already exists, which is why immunologically “cold” ...

Generative AI is rapidly entering oncology, from literature review and medical writing to trial prescreening and clinical ...

Long-term exposure to cigarette smoke reshapes distinct populations of lung stem cells, and the reshaped cell state deciding ...

Engineered bacteria are moving from curiosity to a funded platform. A five-year, $13.1 million National Institutes of Health ...

Children, Families, and the 2026 Revised Blood Guidance for Jehovah's Witnesses - An Update for Pediatric Hematology and ...

What 195 Clinical Trials Reveal About the State of Artificial Intelligence in Oncology and Hematology in 2026.

Artificial intelligence (AI) is increasingly used in oncology to support tasks such as clinical-trial matching, evidence ...

A Bullish Biotech Funding Market and a Higher Bar for Companies Seeking Capital - Importance of milestone-based development ...

Breast Cancer Awareness Month has evolved far beyond a public-health campaign. Over four decades, patient advocacy, philanthropy, data collection, molecular science, and increasingly sophisticated ...

Neil Kramer, MD, is a rheumatologist at Atlantic Health Overlook Medical Center, Physician Researcher, Atlantic Health ...

CAR-T therapy, which transformed the treatment of B-cell blood cancers, is now being tested as a way to reset the immune system in severe ...

Calvin Chao, MD, MBA, Vice President of Medical Science at Artera, is a medical executive with expertise spanning oncology, ...